Month: May 2020

2020 m. gegužės 15 d. AB „Linas“ visuotinis akcininkų susirinkimas patvirtino audituotas AB „Linas“ 2019 metų konsoliduotas metines finansines ataskaitas, parengtas pagal ES priimtus Tarptautinius finansinės atskaitomybės standartus ir pritarė 2019 m. konsoliduotam metiniam pranešimui..AB „Linas“ įmonių grupės 2019 metų pardavimo pajamos sudarė 12,98 mln. eurų, kai 2018 m.– 12,71 mln. eurų. Bendrovės pardavimo pajamos 2019 m. buvo 12,97 mln. eurų, kai 2018 m.– 12,71 mln. eurų.AB „Linas“ įmonių grupės 2019 metų grynasis pelnas– 108,70 tūkst. eurų. 2018 m. Grupės rezultatas – grynasis pelnas 507,52 tūkst. eurų. Bendrovės grynasis pelnas 2019 m. 167,79 tūkst. eurų, 2018 m. – 892 tūkst. eurų.Pateikiame AB „Linas“ ir įmonių grupės audituotą 2019 m. metinę informaciją..AB „Linas“ finansų vadovasEgidijus Mikeliūnas+370 45 506100PriedasLinas...

Not for distribution to United States newswire services or dissemination in the United States.TORONTO, May 15, 2020 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) announces that it has entered into an agreement with Sprott Capital Partners LP on its own behalf and, if applicable, of a syndicate of underwriters (together, the “Underwriter”) pursuant to which the Underwriter has agreed to purchase, on a bought deal basis, 30,769,231 units of the Company (the “Units”) at a price of C$0.39 per Unit (the “Issue Price”) for gross proceeds of approximately C$12 million (the “Offering”). Each Unit is comprised of one (1) common share in the capital of the Company (each, a “Common Shares”) and one half of one Common Share purchase warrant (each whole warrant, a “Warrant”) entitling the holder to purchase...

– Study Showed High Variability in Levels of CSF Biomarkers Over 28 Days –– Drug Was Safe and Well-tolerated –AUSTIN, Texas, May 15, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) today reported top-line results from a Phase 2b study of PTI-125, its lead investigational drug, in patients with Alzheimer’s disease. This study did not meet its primary endpoint. The pre-specified primary endpoint was a statistically significant effect of PTI-125 versus placebo on cerebrospinal fluid (CSF) levels of tau protein and other biomarker assessments from baseline to Day 28. PTI-125 significantly reduced a secondary endpoint, CSF levels of IL1-beta (p

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICESTORONTO, May 15, 2020 (GLOBE NEWSWIRE) — FAX Capital Corp. (FAX Capital or the Company) (TSX: FXC & FXC.WT) today introduced its initial investments and announced its results for the three months ended March 31, 2020. Operating Highlights:Deployed $35.3 million of capital during the period into three public company investments: Hamilton Thorne Ltd. (TSXV:HTL), Information Services Corp. (TSX:ISV) and Points International Ltd. (TSX:PTS) (Nasdaq:PCOM).Book value of $4.13 per subordinate voting share and multiple voting share (collectively, the shares), down 4.8% from Q4 2019, with outperformance during the period relative to the broader Canadian market driven primarily by the Company’s substantial cash balance.Held a cash balance at the end of...

BW Energy will release its Q1 2020 results on Wednesday 20 May at 07:30 CEST.A conference call followed by Q&A will be hosted by CEO Carl K. Arnet, CFO Knut R. Sæthre and COO Lin G. Espey the same day at 14:00 CEST.Conference call information:To dial in to the conference call where the first quarter results and Q&A will be hosted, please dial in to one of the following numbers:Norway: +47 23 96 39 38France: +33 170 750 737Singapore: +65 64 08 57 68United Kingdom: +44 333 3009 034United States: +1 833 526 8382  You can also follow the presentation via webcast with supporting slides, available on:  https://bwe.eventcdn.net/2020q1/ Please note, that if you follow the webcast via the above URL, you will experience a 30 second delay compared to the main conference call.For further information, please contact:Knut R. Sæthre, CFO BW...

Resolutions of AB “Linas” Repeated Annual General Meeting of Shareholders dated on 15 May 2020:1. Attention is paid to the auditor’s conclusions confirming AB “Linas” consolidated and Company’s financial accountability of year 2019 and  agreed to the consolidated annual report of the company of year 2019.2. AB “Linas” consolidated and company’s annual financial statements for the year 2019 are confirmed and it was agreed to consolidated annual report for the year 2019.3 AB “Linas” profit (loss) allocation is confirmed:1) retained profit of the previous financial year at the end of the accounting year – 553,510  EUR;2) net profit of the accounting year  167,792  EUR;3) profit (loss) of the accounting financial year unrecognized in the statement of comprehensive income – 0 EUR;4) transfers from mandatory reserve  0 EUR;5) transfers...

AB „Linas“ 2020 m. gegužės 15 d. įvykusio pakartotinio visuotinio akcininkų susirinkimo sprendimai:1. Atsižvelgta į auditoriaus išvadas tvirtinant AB „Linas“ konsoliduotų ir Bendrovės 2019 m. finansinių ataskaitų rinkinį bei pritariant Bendrovės 2019 m. konsoliduotam metiniam pranešimui.2. Patvirtinta 2019 m. AB „Linas“ konsoliduotas ir Bendrovės metines finansines ataskaitas ir pritarta 2019 m. konsoliduotam metiniam pranešimui.3. Patvirtintas 2019 m. AB „Linas“ pelno (nuostolių) paskirstymas:1) ankstesnių finansinių metų nepaskirstytasis pelnas ataskaitinių finansinių metų pabaigoje – 553.510 EUR;2) grynasis ataskaitinių finansinių metų pelnas 167.792 EUR;3) bendrųjų pajamų ataskaitoje nepripažintas ataskaitinių finansinių metų pelnas (nuostoliai)  0 EUR;4) pervedimai iš privalomojo rezervo  0 EUR;5) pervedimai iš rezervo verslo projektų...

Norwood, MA, May 15, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will be presenting at two upcoming virtual investor conferences. The following are the details for the conferences: 2020 RBC Capital Markets Global Healthcare ConferenceEvent: Fireside Chat Discussion and Q&ADate and Time: Tuesday, May 19, 2020 at 10:55am ESTJefferies Virtual Global Healthcare ConferenceEvent: Fireside Chat Discussion and Q&ADate and Time: Thursday, June 4, 2020 at 11:00am EST An audio webcast of the presentations will be accessible on the Events page of the Investors section of the Corbus...

REDWOOD CITY, Calif., May 15, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data highlighting the use of the company’s proprietary blood tests to advance precision oncology across the continuum of care at the upcoming 2020 American Society of Clinical Oncology (ASCO) Annual Meeting, being held from May 29-31; and the AACR Virtual Annual Meeting II, scheduled for June 22-24.More than 25 abstracts, now online, demonstrate how blood-based comprehensive genotyping is integral to the adoption of precision oncology in advanced cancer. The data highlights the use of Guardant360 and GuardantOMNI liquid biopsy tests to detect clinically actionable mutations and to help inform treatment for patients as their cancer progresses.  Key findings demonstrate...

WALL, N.J., May 15, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric software and hardware solutions for strong, convenient user authentication and large-scale identity, today reported results for its year ended December 31, 2019 and preliminary results for its first quarter ended March 31, 2020 (Q1’20). BIO-key will host a conference call today at 10:00 a.m. ET (details below) to review its results and outlook.Recent Highlights:BIO-key Africa through our partner TTI won a $30M contract to deploy biometric solutions for the enrollment and the positive identification of millions of customers for a leading Nigerian telecom.BIO-key Secures $45M Contract in Nigeria along with Exponential Launch Africa Limited (ELA) an affiliate of Technology Transfer Institute of Africa (TTI) and...